Researchers identify incidence and risk factors for new-onset interstitial lung disease in systemic sclerosis

Shortness of breath (stage two or higher based on the New York Heart Association classification system)
Male sex
Age
Elevated inflammatory markers
Hemoglobin level
Anti-topoisomerase I antibodies (anti-topo I)
Anti-centromere antibodies